|
gptkbp:instance_of
|
gptkb:healthcare_organization
|
|
gptkbp:bfsLayer
|
3
|
|
gptkbp:bfsParent
|
gptkb:healthcare_organization
|
|
gptkbp:advocates_for
|
gptkb:National_Ovarian_Cancer_Coalition
gptkb:Ovarian_Cancer_Canada
gptkb:Ovarian_Cancer_National_Alliance
gptkb:Ovarian_Cancer_Research_Fund_Alliance
|
|
gptkbp:affects
|
Ovaries
|
|
gptkbp:clinical_trial
|
Phase III trials
Phase I trials
Phase II trials
Phase IV trials
|
|
gptkbp:current_use
|
gptkb:Endometriosis
gptkb:Polycystic_ovary_syndrome
Infertility
|
|
gptkbp:end_of_life
|
5-year survival rate
10-year survival rate
|
|
gptkbp:genetic_diversity
|
gptkb:Lynch_syndrome
BRC A1 mutation
BRC A2 mutation
|
|
gptkbp:global_presence
|
Approximately 300,000 cases annually
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Ovarian Cancer
|
|
gptkbp:is_involved_in
|
gptkb:Ovarian_Cancer_Alliance
gptkb:Ovarian_Cancer_Support_Network
Ovarian Cancer Community
|
|
gptkbp:is_protected_by
|
gptkb:Oral_contraceptives
Regular exercise
Genetic testing
Healthy diet
|
|
gptkbp:is_standardized_by
|
gptkb:Germ_cell_tumors
gptkb:Epithelial_ovarian_cancer
Stromal tumors
|
|
gptkbp:lifespan
|
Approximately 185,000 deaths annually
|
|
gptkbp:number_of_stages
|
Stage I
Stage II
Stage III
Stage IV
|
|
gptkbp:public_awareness
|
September
|
|
gptkbp:research_focus
|
gptkb:vaccine
Targeted therapy
Early detection
|
|
gptkbp:risk_factor
|
gptkb:television_series
Family history
Genetic mutations
|
|
gptkbp:social_responsibility
|
Ultrasound
CT scan
Blood tests
Pelvic exam
|
|
gptkbp:symptoms
|
Pelvic pain
Abdominal bloating
Difficulty eating
Urinary urgency
|
|
gptkbp:treatment
|
gptkb:hospital
Chemotherapy
Radiation therapy
Targeted therapies
PARP inhibitors
Platinum-based chemotherapy
|